kabutan

NIPPON CHEMIPHAR CO., LTD.(4539) Summary

4539
TSE Standard
NIPPON CHEMIPHAR CO., LTD.
1,706
JPY
-20
(-1.16%)
Apr 28, 3:10 pm JST
10.71
USD
Apr 28, 2:10 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
41.2
PBR
0.32
Yield
2.93%
Margin Trading Ratio
Stock Price
Apr 28, 2026
Opening Apr 28, 9:00 am
1,709 JPY 10.72 USD
Previous Close Apr 27
1,726 JPY 10.83 USD
High Apr 28, 9:00 am
1,709 JPY 10.74 USD
Low Apr 28, 1:53 pm
1,680 JPY 10.56 USD
Volume
3,500
Trading Value
6.00M JPY 0.04M USD
VWAP
1689.86 JPY 10.61 USD
Minimum Trading Value
170,600 JPY 1,071 USD
Market Cap
7.27B JPY 0.05B USD
Number of Trades
15
Liquidity & Number of Trades
As of Apr 28, 2026
Liquidity
Slightly Low
1-Year Average
13
1-Year High Sep 11, 2025
83
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 179,700
Apr 17, 2026 0 179,600
Apr 10, 2026 0 178,200
Apr 3, 2026 0 176,700
Mar 27, 2026 0 174,700
Company Profile
NIPPON CHEMIPHAR CO., LTD. is a mid-sized pharmaceutical company. Its main focus is on generic drugs, with uric acid and pain relief medications as its core products. The company is also actively engaged in new drug development.
Sector
Pharmaceuticals
NIPPON CHEMIPHAR CO., LTD. operates in the medical, health, and beauty-related sectors, with pharmaceutical products at its core. In its primary pharmaceutical business, the company manufactures and sells prescription drugs, with a high proportion of generic medicines, while also pursuing new drug development. The company promotes its business in collaboration with domestic and overseas subsidiaries and affiliates. Additionally, it is involved in other ventures such as safety testing services, healthcare business, and real estate leasing. The group comprises six companies, establishing an integrated system from drug development to manufacturing and sales. While maintaining its strength in the prescription drug field, NIPPON CHEMIPHAR CO., LTD. has expanded into related areas, solidifying its position as a comprehensive medical and health-related enterprise.